TABLE 3.
Hemoglobin concentration and presence of iron deficiency (defined by a zinc protoporphyrin value ≥80 µmol/mol heme) at 6-mo follow-up, according to treatment with immediate or delayed iron1
| CM | SMA | CC | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Immediate | Delayed | P 2 | Immediate | Delayed | P 2 | Immediate | Delayed | P 2 | |
| Hemoglobin,3 g/L | 12.4 ± 1.4 | 11.8 ± 1.3 | 0.13 | 11.1 ± 2.2 | 11.7 ± 1.1 | 0.16 | 12.0 ± 1.1 | 12.1 ± 1.1 | 0.79 |
| Iron deficiency | 8/37 (21.6) | 10/31 (32.3) | 0.32 | 19/34 (55.9) | 14/36 (38.9) | 0.15 | 9/19 (47.4) | 5/16 (31.3) | 0.33 |
1
Values are means ± SDs or n/N (%). CC, community children; CM, cerebral malaria; SMA, severe malarial anemia.
2
t Test for comparison of hemoglobin concentration; chi-square test for comparison of prevalence of iron deficiency.
3
CM immediate n = 31, delayed n = 27; SMA immediate n = 28, delayed n = 33; CC immediate n = 18, delayed n = 16. Some children who were seen at the 6-mo time point did not have hemoglobin tested owing to study errors in sample collection at this time point.